Dicerna Pharmaceuticals, Inc.
Beta catenin nucleic acid inhibitor molecule

Abstract:

Provided herein is a potent, optimized .beta.-catenin nucleic acid inhibitor molecule with a unique pattern of modified nucleotides. Also provided are methods and compositions for reducing .beta.-catenin expression and methods and compositions for treating cancer.